Naturally mutagenic sequence diversity in a human type II topoisomerase is a research paper published in Proceedings of the National Academy of Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: T32-GM008403-28
HHS | National Institutes of Health
Grant: R01-CA077373
HHS | National Institutes of Health
Grant: R35-CA263778
HHS | NIH | National Cancer Institute
Grant: CA 216010
NCI NIH HHS
Grant: R03 CA216010
NIGMS NIH HHS
Grant: R01 GM116961
NCI NIH HHS
Grant: R35 CA263778
NIGMS NIH HHS
Grant: T32 GM135131
NCI NIH HHS
Grant: R01 CA077373
NIGMS NIH HHS
Grant: T32 GM008403
National Institutes of Health
Grant: 7R01CA077373-16
Biochemical Analyses of Type II DNA Topoisomerases
National Institutes of Health
Grant: 5R03CA216010-02
Novel approaches for studying topoisomerase 2 targeting anti-cancer drugs
National Institutes of Health
Grant: 5R01GM116961-04
Breakthrough Molecular Dynamics Research via an Anton2 Supercomputer
National Institutes of Health
Grant: 5T32GM008403-22
PROGRAM IN MOLECULAR BIOPHYSICS
National Institutes of Health
Grant: 5R35CA263778-05
Understanding and exploiting DNA topoisomerases in cancer biology
FWCI
1.00
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords